2013-2016 National Tuberculosis Control Program Laboratory Network Strategic Plan: A Sub-Plan of the Philippine Plan of Action to Control Tuberculosis (PhilPACT). National TB Reference Laboratory and Ministry of Health, Philippines. (2015)

immage

The 2013-2016 Laboratory Network Strategic Plan (LNSP) is a sub-plan of the 2010-2016 Philippine Plan of Action to Control Tuberculosis (PhilPACT). This plan will serve as a roadmap to strengthen the network’s laboratory services to control TB. It is aligned with various existing strategic plans to improve the laboratory facilities and activities in the country.


Keywords: TB, diagnostic, funding, services

 

Download Publication

Discussion Paper - Gender and Tuberculosis. UNDP. (2015)

immage

This discussion paper on gender and TB is intended to support practitioners, civil society and government partners wishing to make the investment case for increased and improved TB programming that addresses the specific vulnerabilities and needs of both men and women who are living with or at risk of TB. The paper summarizes the existing evidence base, demonstrating the ways in which gender has an impact on the risks and effects of TB (including those that intersect with HIV), and highlighting existing gaps in data and implementation. This information is useful for UNDP in its role in supporting governments to implement and operationalize the development agenda by 2030, by turning commitments into action.

 

Keywords: HIV, TB, deaths, women, men, mother, children, pregnant, infants

 

Download Publication

Implementing the End TB Strategy: The Essentials. WHO. (2015)

immage

The Essentials provides in-depth explanations of the vision, goal, targets and milestones of the End TB Strategy as well as the key indicators to measure progress. It then outlines the essential features of operationalizing the principles, pillars and components of the End TB Strategy. Country experiences are included throughout as examples in applying elements of the strategy.

The Essentials is organized in three parts: Part I presents the overall approach, principles and the first steps of implementation expected at the country level. Part II explains the vision, goal, indicators, targets and milestones of the Strategy and Part III outlines the policies, the actors and actions needed to help implement the new approaches laid out under the three pillars of the Strategy: (i) Integrated, patient-centred care and prevention; (ii) Bold policies and supportive systems; and (iii) Intensified research and innovation.

 


Keywords: tuberculosis, prevention and control, early diagnosis, TB research

Download Publication

Recommendations on the Management of Human Immunodeficiency Virus and Tuberculosis Coinfection. Centre for Health Protection, Department of Health. (2015)

immage

In Hong Kong, extrapulmonary TB and, at CD4 count <200/μL,pulmonary TB and TB of cervical lymph node are AIDS-defining conditions. From 1996 to 2012, 358 (26.5%) of reported AIDS were defined primarily by TB. In 2005 and 2007, it briefly overtook Pneumocystis jiroveci pneumonia as the most common AIDS-defining condition. It is estimated that 1% of all TB disease in Hong Kong is associated with HIV. The corresponding figure in the US is 8%.


Keywords: Hong Kong, HIV, TB, ART, CD4, treatment, diagnosis

 

Download Publication

Racing to the End TB Finish Line: Tuberculosis Financing in 2014. Stop TB Partnership. (2015)

immage

World leaders are meeting in Addis Ababa, Ethiopia for the UN Financing for Development Conference to discuss financing for the Sustainable Development Goals (SDGs), a new set of global development targets. The draft SDG goals include a target to end the epidemic of tuberculosis by 2030, in line with the
WHO End TB Strategy and the Global Plan to Stop TB 2016-2020.
In order to achieve these targets, increased investments for tuberculosis (TB) will be essential to set the world on course to end TB in our lifetime. However, many countries are failing to step up with the needed investments.

 

 

Keywords: HIV, TB, domestic, financing, investment

 

 

Download Infographic

The Paradigm Shift 2016-2020: Global Plan to End TB. Stop TB Partnership, UNOPS and End TB. (2015)

immage

The Global Plan 2016-2020 sets out the actions and resources needed over the next five years to set the world on a course to end the global TB epidemic by 2030, as endorsed by world leaders in the newly adopted Sustainable Development Goals.

This Plan makes it clear that what is needed to end TB is a paradigm shift - a change in the way we fight TB at every level, in every community, in every health facility, in every country.


Keywords: HIV/AIDS, TB, 90-90-90, community, drug-resistant

Download Publication

Out of Step 2015 TB Policies in 24 Countries - A Survey of Diagnostic and Treatment Practices. Médecins Sans Frontières and Stop TB Partnership. (2015)

immage

The survey was primarily designed to assess the status of national policies in relation to the latest WHO recommendations in five key areas: diagnosis, models of care, treatment of drug-sensitive (DS) TB, treatment of drug-resistant (DR) TB, and the regulatory environment for TB drugs. Where possible, we attempted to assess the extent to which diagnostic policies have been successfully implemented, although this could only be done on a qualitative basis. This survey is a follow-up of the study conducted by MSF in 2014. This updated survey has a broader scope to survey more policy areas and expands the number of surveyed countries from 8 to 24.


Keywords: HIV/AIDS, treatment, diagnosis, data, drugs, drug-resistant

Download Publication

Global Tuberculosis Report 2015. WHO. (2015)

immage

This is the twentieth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care, control and research at global, regional and country levels using data reported by over 200 countries that account for more than 99% of the world's TB cases. In this 2015 edition, particular attention is given to assessment of whether 2015 global TB targets set in the context of the Millennium Development Goals were achieved worldwide and at regional and country levels. 


Keywords: TB, HIV, PLHIV, deaths, treatment, drug-resistant


Download full report

 

Download executive summary

 

Download main text

 

Download country profiles

 

Download regional profiles

 

Download global TB facts 2015

 

Download infographic

Stop TB Partnership - Annual Report 2014. Stop TB Partnership and UNOPS. (2015)

immage

Tuberculosis (TB) is a significant global public health threat. Despite being preventable and curable, the disease is widespread. In 2013, 9 million people fell ill with TB and 1.5 million people died from the disease – including 360,000 people coinfected with HIV. An estimated 550,000 children became ill with TB. The burden of this disease is disproportionately borne by relatively few countries, primarily in the developing world, with the majority of the global TB burden, spread across 22 highburden countries.


Keywords: TB, HIV, drug resistant, healthcare, vaccines, investment

Download Publication

The Missing 3 Million Reach, Treat, Cure Everyone. Stop TB Partnership. (2015)

immage

Who Are the Missed 3 Million: 9 million became ill and 1.5 million died from tuberculosis (TB) in 2013. More than 3 million people with TB were missed and undiagnosed. These include women and children, the poor and malnourished, refugees, migrants, miners, ethnic minorities, homeless and substance users.

 

Keywords: TB cases, drug resistant, treatment, children, deaths

 

 

Download Publication

Pages

Data Dashboard
database
Highlighted publications
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Monitoring_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Fact_Sheets_Nov2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events